King Trumpet and the Immune System: Research Review

King Oyster Mushroom

β-1,6-glucan: the immune-active glucan that distinguishes king trumpet from most medicinal mushrooms

Most medicinal mushroom immune research focuses on β-1,3-glucan. King trumpet (Pleurotus eryngii) contains a structurally distinct β-1,6-glucan that modulates both immune cell activity and gut microbiota composition through different receptor interactions, representing a separate immune pathway.

Wang et al., Frontiers in Nutrition, 2022

NK + CTL cells

natural killer cells and cytotoxic T lymphocytes both activated by P. eryngii polysaccharide in renal cancer-bearing mice (Yang et al., 2013)

Th1 shift

intake of Pleurotus (oyster mushroom) extract produced a Th1 immune phenotype shift in a double-blind, placebo-controlled human RCT (Tanaka et al., 2016)

P. ostreatus caveat

the only human Pleurotus immune RCT used P. ostreatus (Tamogitake), not P. eryngii specifically; genus-level human evidence, not species-specific

Wang et al., Frontiers in Nutrition, 2022

View as image ↗

King trumpet mushroom's immune research gets less attention than turkey tail's PSK or reishi's polysaccharides, but a distinct immune story has accumulated: a specific β-1,6-glucan structure with different receptor interactions than the β-1,3-glucan that dominates most mushroom immune research, NK cell and cytotoxic T lymphocyte activation documented in animal cancer models, macrophage activation evidence from multiple studies, and a human randomized trial showing Th1 immune phenotype shifts from Pleurotus genus intake.

The human evidence caveat is important and stated up front: the only human Pleurotus immune RCT used P. ostreatus (Tamogitake), not P. eryngii specifically. This is genus-level human evidence, not P. eryngii-specific human evidence. It raises the probability that P. eryngii has similar effects; it does not confirm it.

For the broader king trumpet overview, see what is king trumpet mushroom: the meaty mushroom with health benefits.

Why β-1,6-Glucan Is Structurally Different

Most medicinal mushroom immune research focuses on β-1,3-glucan, the polysaccharide backbone that activates Dectin-1 receptors on macrophages, dendritic cells, and neutrophils. The β-1,3 linkage (where glucose molecules are connected at the 1 and 3 positions) is the structural feature that Dectin-1 recognizes.

King trumpet (Pleurotus eryngii) contains a meaningful proportion of β-1,6-glucan, a polysaccharide where glucose units are connected at the 1 and 6 positions. This structural difference matters immunologically because β-1,6-glucan interacts with pattern recognition receptors differently than β-1,3-glucan.

Wang and colleagues (2022) characterized the β-1,6-glucan from P. eryngii and documented its immune and microbiota effects.^[3] The β-1,6-glucan produced immune cell activation and simultaneously enriched specific gut bacteria (Lachnospiraceae and SCFA producers). The dual immune-microbiota effect from a single structural compound suggests the β-1,6-glucan is working through at least two independent pathways: direct immune receptor interaction and prebiotic effect on gut-associated immune tissue.

Zhang and colleagues (2020) reviewed the full structural diversity and bioactivities of P. eryngii polysaccharides across the published literature, confirming that the polysaccharide mixture in king trumpet includes multiple fractions with different structural features and different biological activities.^[1]

NK Cell and Cytotoxic T Lymphocyte Activation

Natural killer cells (NK cells) and cytotoxic T lymphocytes (CTLs) are the two primary immune cell populations that directly kill infected and tumor cells. NK cells operate through innate immunity, attacking cells without prior sensitization; CTLs operate through adaptive immunity, recognizing specific antigens on cell surfaces.

Yang and colleagues (2013) documented activation of both populations by P. eryngii polysaccharide in a mouse renal cancer model.^[2] Mice bearing renal cancer and treated with P. eryngii polysaccharide showed increased NK cell and CTL counts and activity compared to untreated controls. The tumor inhibition observed in these mice was attributed in part to this immune cell activation, suggesting the polysaccharide was acting through immune activation rather than direct tumor cell toxicity alone.

The simultaneous activation of both NK cells (innate) and CTLs (adaptive) is significant because it represents broad immune enhancement across both arms of cell-mediated immunity. Compounds that activate only one arm may have blind spots for cancer cells that evade one type of recognition; compounds activating both provide more complete immune surveillance.

Macrophage Activation and Immune Regulation

Zhang's 2020 systematic review documented macrophage activation as one of the most consistently observed immune effects across P. eryngii polysaccharide research.^[1] Macrophages are the frontline cells of innate immunity, performing phagocytosis (engulfing and destroying pathogens), presenting antigens to T cells, and coordinating inflammatory responses.

P. eryngii polysaccharide treatment consistently increased macrophage phagocytic activity across multiple studies reviewed by Zhang, along with nitric oxide production (a signaling molecule for macrophage activation) and cytokine secretion patterns consistent with M1 macrophage activation (the pro-inflammatory, infection-fighting phenotype as opposed to the M2 anti-inflammatory phenotype).

Ma and colleagues (2020) documented the anti-inflammatory side of P. eryngii polysaccharide macrophage interaction alongside the immune activation.^[5] The same compound that activates macrophages against pathogens also blocks the excessive NF-kB signaling that drives chronic inflammation. This dual regulation, activating appropriate immune responses while suppressing excessive inflammatory responses, is consistent with immunomodulation rather than simple immune stimulation.

The Human Evidence: Tanaka 2016

The most relevant human evidence comes from a double-blind, placebo-controlled RCT by Tanaka and colleagues (2016) on Oyster mushroom (P. ostreatus, called Tamogitake) extract.^[4]

The study found that consumption of Tamogitake extract produced enhancement of the Th1 immune phenotype in participants. The Th1/Th2 balance is an important aspect of immune regulation: Th1 responses are associated with cellular immunity against viruses and cancer; Th2 responses are associated with humoral immunity and allergic responses. Excessive Th2 dominance is associated with allergic conditions and reduced cancer immune surveillance; Th1 enhancement supports the immune system's ability to fight infections and identify tumor cells.

Participants consuming the Tamogitake extract showed significant Th1 phenotype shift compared to the placebo group.

The species caveat: Tamogitake is P. ostreatus (oyster mushroom), not P. eryngii (king trumpet). Both are in the Pleurotus genus and share similar polysaccharide profiles, but they are distinct species. This is genus-level human evidence, not P. eryngii-specific human evidence. The probability that P. eryngii produces similar effects is reasonable given the shared genus and polysaccharide chemistry, but it is not confirmed.

P. eryngii-specific human immune trials have not been published. This is a research gap.

The β-1,6-Glucan's Unique Position

The β-1,6-glucan story (Wang et al. 2022) is the most structurally distinctive aspect of king trumpet's immune profile.^[3] While other mushrooms are studied for their β-1,3-glucan content, the specific β-1,6-glucan fraction in P. eryngii may offer activity through receptor pathways that complement rather than duplicate the β-1,3-glucan effects of other medicinal mushrooms.

This is relevant for people who take multiple mushroom supplements or combine king trumpet with other medicinal mushrooms: king trumpet's β-1,6-glucan may engage different immune receptor pathways than the β-1,3-glucan in reishi, lion's mane, turkey tail, or chaga. If the structural difference translates to different receptor interactions, combining king trumpet with β-1,3-glucan-rich mushrooms could in principle engage a broader range of immune receptor pathways than either alone.

This hypothesis is scientifically grounded but not tested in combination studies.

Honest Evidence Assessment

King trumpet has a mechanistically coherent and multi-study preclinical immune evidence base: β-1,6-glucan with documented immune receptor interaction (Wang 2022), NK cell and CTL activation in animal cancer models (Yang 2013), macrophage activation across multiple studies (Zhang 2020 review), anti-inflammatory cytokine modulation (Ma 2020), and genus-level human Th1 shift data from a Pleurotus RCT (Tanaka 2016).

What is missing: a human clinical trial specifically using P. eryngii extract and measuring immune cell populations or infection resistance outcomes. The Tanaka 2016 data bridges the gap partially but cannot substitute for P. eryngii-specific human immune evidence.

Practically, king trumpet is a nutritionally valuable food with documented immune-relevant bioactive compounds. Its β-1,6-glucan is structurally distinctive and its immune activation mechanisms are well-documented at the preclinical level. The human evidence gap is real but the mechanistic foundation is substantially more developed than most consumer content acknowledges.

The Bottom Line

King trumpet mushroom (P. eryngii) has documented immune effects through multiple mechanisms: β-1,6-glucan (structurally distinct from β-1,3-glucan in most medicinal mushrooms) that modulates immunity and gut microbiota (Wang et al., 2022); NK cell and CTL activation in animal cancer models (Yang et al., 2013); macrophage activation documented across multiple studies (Zhang et al., 2020 review); and NF-kB pathway anti-inflammatory immunomodulation (Ma et al., 2020). The only human Pleurotus immune RCT (Tanaka et al., 2016) used P. ostreatus (not P. eryngii) and showed significant Th1 immune enhancement. P. eryngii-specific human immune trials have not been conducted.

Frequently Asked Questions

Does king trumpet mushroom boost the immune system?

King trumpet mushroom activates NK cells, cytotoxic T lymphocytes, and macrophages in preclinical research, through polysaccharides including a structurally distinct β-1,6-glucan (Wang et al., 2022). A human Pleurotus genus RCT (Tanaka et al., 2016) showed Th1 immune phenotype enhancement, though it used P. ostreatus rather than P. eryngii specifically. The preclinical evidence for king trumpet immune activation is robust; P. eryngii-specific human immune trials have not been published.

What are the health benefits of king trumpet mushroom?

Documented benefits in research include: immune activation (NK cells, CTLs, macrophages), anti-inflammatory activity (NF-kB/MAPK suppression), antioxidant effects via ergothioneine, gut microbiome support via β-1,6-glucan prebiotic effects, bone health effects (vitamin D2 pathway and ergosterol peroxide), antitumor activity in renal, liver, colon, and breast cancer models, and cholesterol-relevant effects from lovastatin content. The human clinical evidence is more limited than the preclinical evidence base.

Is king trumpet the same as king oyster for immune support?

Yes, king trumpet and king oyster are both common names for Pleurotus eryngii (also called king trumpet, king oyster, or eringi). Same species, same immune research base. The β-1,6-glucan immune data (Wang 2022), NK cell activation (Yang 2013), and anti-inflammatory polysaccharide work (Ma 2020) all apply to the same species regardless of the name used.

How much king trumpet mushroom should I eat for immune benefits?

The research does not establish a specific dietary dose for immune effects. Hu et al.'s colitis study used dietary incorporation rather than a measured extract dose, suggesting consumption at typical culinary quantities may produce measurable effects. The human Pleurotus RCT (Tanaka 2016) used an extract standardized to polysaccharide content at a specific dose. Without P. eryngii-specific human immune dose data, general dietary guidance is not supported by direct research. Including king trumpet as a regular dietary mushroom is consistent with the research; specific dose claims are not.

Is king trumpet mushroom anti-inflammatory?

Yes. King trumpet polysaccharides block NF-kB and MAPK inflammatory signaling pathways, suppressing TNF-alpha, IL-6, IL-1beta, and nitric oxide production (Ma et al., 2020). A novel anti-inflammatory protein has also been isolated from P. eryngii (Yuan et al., 2017). The anti-inflammatory and immunomodulatory effects appear to work simultaneously: the same polysaccharides that activate macrophages against pathogens also suppress the excessive inflammatory signaling associated with chronic disease.

Sources & References

1. 1RTHM-01310·Zhang, Bingru et al. (2020). “Extraction, structure and bioactivities of the polysaccharides from Pleurotus eryngii: A review..” International journal of biological macromolecules.Study breakdown →PubMed →↩
2. 2RTHM-00569·Yang, Zengyue et al. (2013). “Antitumor activity of a polysaccharide from Pleurotus eryngii on mice bearing renal cancer..” Carbohydrate polymers.Study breakdown →PubMed →↩
3. 3RTHM-00801·Wang, Xue et al. (2022). “β-1,6-Glucan From Pleurotus eryngii Modulates the Immunity and Gut Microbiota..” Frontiers in immunology.Study breakdown →PubMed →↩
4. 4RTHM-00830·Tanaka, Aiko et al. (2016). “Enhancement of the Th1-phenotype immune system by the intake of Oyster mushroom (Tamogitake) extract in a double-blind, placebo-controlled study..” Journal of traditional and complementary medicine.Study breakdown →PubMed →↩
5. 5RTHM-01247·Ma, Gaoxing et al. (2020). “Preparation of newly identified polysaccharide from Pleurotus eryngii and its anti-inflammation activities potential..” Journal of food science.Study breakdown →PubMed →↩